The Impact of Nosocomial Infections on Hospital Care Costs

Infection, Supplement

Volumn 31, Issue 2, 2003, Pages 35-43

  Lauria, F N ^a   Angeletti, C ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; COST; COST BENEFIT ANALYSIS; ECONOMIC ASPECT; EVALUATION; HOSPITAL CARE; HOSPITAL INFECTION; INCIDENCE; MANAGEMENT; METHODOLOGY; ORGANIZATION; PHYSICIAN; REVIEW;

CROSS INFECTION; HOSPITAL COSTS; HUMANS; INFECTION CONTROL; LENGTH OF STAY; WORLD HEALTH;

EID: 0442276254     PISSN: 01732129     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (33)

1. Fraser VJ: Starting to learn about the costs of NIs in the new millenium: where do we go from here? Infect Control Hosp Epidemiol 2002;23: 174-175.
2. Plowman R., Graves N., Griffin MAS, Roberts JA, Swan AV, Cookson B, Taylor L: The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. J Hosp Infect 2001;47:198-209.
3. Orsi GB, Di Stefano L, Noah N: Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs. Infect Control Hosp Epidemiol 2002; 23: 190-197
4. Whitehouse JD, Friedman ND, Kirkland KB, Richardson WJ: The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol 2002;23: 183-189.
5. Saint S, Veenstra DL, Lipsky BA: The clinical and economic consequences of nosocomial central venous catheter-related infection: are antimicrobial catheters useful? Infect Control Hosp Epidemiol 2002;6: 375-380.
6. Abramson MA, Sexton DJ: Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs? Infect Control Hosp Epidemiol 1999;20: 408-411.
7. Stosor V, Peterson LR, Postelnick M, Noskin GA.: Enterococcus faecium bacteremia: does vancomycin resistance make a difference? Arch Intern Med 1998 Mar 9;158:522-527.
8. Stone PW, Larson E, Kawar LN: A systematic audit of economic evidence linking nosocomial infection and infection control interventions: 1990-2000. Am J Infect Control 2002;30:145-152.
9. Saint S. Clinical and economic consequences of nosocomial catheter-related bacteriuria. Am J Infect Control 2000;28: 68-75.
10. Allman RM, Goode PS, Burst N, Bartolucci AA, Thomas DR: Pressure ulcers, hospital complications, and disease severity: impact on hospital costs and length of stay. ADV Wound Care 1999; 12:22-30.
11. Wakefield DS, Pfaller MA, Hammons GT, Massanari M: Use of the appropriateness evaluation protocol for estimating the incremental costs associated with nosocomial infections. Med Care 1987;25: 481-488.
12. Wakefield DS, Pfaller M, Ludke RL, Wenzel RP: Methods for estimating days of hospitalization due to nosocomial infections. Med Care 1992; 30: 373-376.
13. Merle V, Germain GM, Chamouni P, Daubert H, Froment L, Michot F, Teniere P, Czernichow P: Assessment of prolonged hospital stay attributable to surgical site in infections using appropriateness evaluation protocol. Am J Infect Control 2000;28: 109-115.
14. Vilella A, Part A, Trilla A, Bayas JM, Asenjo MA, Salleras L: Excess length of stay attributable to nosocomial bacteremia usefulness of the hospitalization appropriateness protocol. Med Clin 1999; 113: 608-610.
15. Hollenbeak CS, Murphy D, Dunagan WC, Fraser VJ: Nonrandom selection and the attributable cost of surgical-site infections. Infect Control Hosp Epidemiol 2002;23: 177-182.
16. Garibaldi RA, Mooney BR, Epstein BJ, Britt MR: An evaluation of daily bacteriologic monitoring to identify preventable episodes of catheter-associated urinary tract infection. Infect Control 1982; 3: 466-470.
17. Plowman R, Graves N, Esquivel J, Roberts A: An economic model to assess the cost and benefits of the routine use of silver alloy coated urinary catheters to reduce the risk of urinary tract infections in catheterized patients. J Hosp Infect 2001;48: 33-42.
18. Karchemer TB, Giannetta ET, Muto CA, Strain BA, Farr BM: A randomized crossover study of silver-coated urinary catheters in hospitalized patients. Arch Intern Med 2000; 160: 3294-3298.
19. Montecalvo MA, Jarvis WR, Uman J, Shay DK, Petrullo C, Horowitz HW, Wormser GP: Cost and savings associated with infection control measures that reduce transmission of vancomycin-resistant enterococci in an endemic setting. Infect Control Hosp Epidemiol 2001; 22: 437-442.
20. Jernigan JA, Clemence MA, Stott GA, Titus MG, Alexrander CH, Palumbo CM, Farr BM: Control of methicillin-resistant Staphylococcus aureus at a university hospital: one decade later. Infect Control Hosp Epidemiol 1995; 16: 686-696.
21. Chaix C, Durant-Zaleski I, Alberti C, Brun-Buisson C: Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA 1999;282: 1745-1751.
22. Papia G, Louie M, Tralla A, Johnson C, Collins V, Simor AE: Screening high-risk patients for the methicllin-resistant Staphylococcus aureus on admission to the hospital: is it cost effective? Infect Control Hosp Epidemiol 1999; 20: 473-477.
23. Nicotra D, Ulrich C: Process improvement plan for the reduction of nosocomial pneumonia in patients on ventilators. J Nurs Care Qual 1996; 10: 18-23.
24. Hess D, Burns E, Roagnoli D, Kacmarek RM: Weekly ventilator circuit changes. A strategy to reduce costs without affecting pneumonia rates. Anesthesiology 1995; 82: 903-11.
25. Shor AF, O'Malley PG: Continuous subglotting suctioning for the prevention of ventilator-associated pneumonia: potential economic implications. Chest 2001;119: 228-235
26. MMWR 1992; 41: 783-787.
27. Haley RW, Culver DH, White JW, Morgan WM, Emori TG, Munn VP, Hooton TM: The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985;12: 182-205.
28. Moro MI, Gandin C, Bella A, Siepi G Petrosillo N: A national survey on the surveillance and control of nosocomial infections In public hospitals in Italy. Rapporti ISTISAN 2001; 01/4.
29. Wenzel RP: The economics of nosocomial infections. J Hosp Infect 1995; 31: 79-87.
30. Townsend TR, Wenzel RP: Nosocomial bloodstream infections in a newborn intensive care unit. Am J Epidemiol 1981; 114: 73-80.
31. Leu HS, Kaiser KL, Meri M, Woolson RF, Wenzel RP: Hospital acquired pneumonia: attributable mortality and morbidity. Am J Epidemiol 1989; 8:56-60.
32. Pitter D, Tarara D, Wenzel RP: Nosocomial bloodstream infection in critically ill patients, excess length of stay, extra costs, and attributable mortality. JAMA 1994; 271: 1598-1601.
33. Wenzel RP: Hospital acquired pneumonia: overview of the current state of the art for prevention and control. Eur J Clin Microbiol 1989; 8: 56-60.